CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Revenue		$ 29,968,000	$ 23,394,000
Cost of revenue		14,157,000	12,425,000
Gross profit		15,811,000	10,969,000
Operating expenses:
Research and development		9,746,000	10,533,000
Sales and marketing		10,022,000	10,559,000
General and administrative		6,553,000	6,677,000
Total operating expenses		26,321,000	27,769,000
Loss from operations		(10,510,000)	(16,800,000)
Investment income		384,000	610,000
Interest expense		(921,000)	(923,000)
Loss before provision for income taxes		(11,047,000)	(17,113,000)
Income tax provision		6,000	0
Net loss		$ (11,053,000)	$ (17,113,000)
Net loss per share, basic (USD per share)		$ (0.27)	$ (0.50)
Net loss per share, diluted (USD per share)		$ (0.27)	$ (0.50)
Weighted average shares used in computing net loss per share attributable to Class A and Class B common stockholders, basic (See Note 14) (in shares)	[1]	40,225,239	33,922,683
Weighted average shares used in computing net loss per share attributable to Class A and Class B common stockholders, diluted (See Note 14) (in shares)	[1]	40,225,239	33,922,683

[1] On July 6, 2023, all shares of the Company’s then outstanding Class B common stock were automatically converted into the same number of Class A common stock, pursuant to the terms of the Company’s Amended and Restated Certificate of Incorporation. No additional shares of Class B common stock will be issued following such conversion. See Note 15 for further details.